|
2019 Conference Publication Synergistic anti-cancer activity of auranofin with anti-PD-L1 therapy in triple negative breast cancerRaninga, P., Lee, A., Sinha, D., Shin, Y-Y., Mittal, D., Kalimutho, M. and Khanna, K. K. (2019). Synergistic anti-cancer activity of auranofin with anti-PD-L1 therapy in triple negative breast cancer. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 1 October 2019. Oxford, United Kingdom: Oxford University Press. |
|
2019 Conference Publication Strategic inhibition of CEP55 in aggressive breast cancer leads to mitotic catastropheSinha, D. (2019). Strategic inhibition of CEP55 in aggressive breast cancer leads to mitotic catastrophe. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 1 October 2019. Oxford, United Kingdom: Oxford University Press. |
|
2019 Journal Article Prophylactic and therapeutic strategies for Epstein-Barr virus-associated diseases: emerging strategies for clinical developmentDasari, Vijayendra, Sinha, Debottam, Neller, Michelle A, Smith, Corey and Khanna, Rajiv (2019). Prophylactic and therapeutic strategies for Epstein-Barr virus-associated diseases: emerging strategies for clinical development. Expert Review of Vaccines, 18 (5), 457-474. doi: 10.1080/14760584.2019.1605906 |
|
2018 Conference Publication CEP55 over-expression causes genomic instability to initiate spontaneous tumour formation in vivoSinha, D., Kalimutho, M., Bain, A.L. and Khanna, K.K. (2018). CEP55 over-expression causes genomic instability to initiate spontaneous tumour formation in vivo. 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, Netherlands, 30 June – 3 July 2018. London, United Kingdom: Elsevier. doi: 10.1136/esmoopen-2018-eacr25.730 |
|
2017 Conference Publication Targeting thioredoxin reductase 1 in novel combination therapies in p53 mutant triple negative breast cancerRaninga, P., Kalimutho, M., Sinha, D., Bain, A., Tonissen, K. and Khanna, K. K. (2017). Targeting thioredoxin reductase 1 in novel combination therapies in p53 mutant triple negative breast cancer. 42nd European Society for Medical Oncology Congress (ESMO), Madrid, Spain, 8-12 September 2017. Oxford, United Kingdom: Oxford University Press. |
|
2017 Conference Publication Synergistic inhibition of CEP55 induces mitotic catastrophe and specifically targets aggressive breast cancerSinha, D., Kalimutho, M., Lopez, A. J. and Khanna, K. K. (2017). Synergistic inhibition of CEP55 induces mitotic catastrophe and specifically targets aggressive breast cancer. 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain, 8-12 September 2017. Oxford, United Kingdom: OXFORD UNIV. |
|
2017 Conference Publication Dual inhibition of MEK1/2 and PLK1 specifically targets aggressive breast cancer cell population with CEP55 elevated expressionSinha, Debottam, Kalimutho, Murugan, Lopez, J. Alejandro and Khanna, Kum Kum (2017). Dual inhibition of MEK1/2 and PLK1 specifically targets aggressive breast cancer cell population with CEP55 elevated expression. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC , United States, 1-5 April 2017. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2017-1144 |
|
2017 Journal Article Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiaeKalimutho, Murugan, Bain, Amanda L., Mukherjee, Bipasha, Nag, Purba, Nanayakkara, Devathri M., Harten, Sarah K., Harris, Janelle L., Subramanian, Goutham N., Sinha, Debottam, Shirasawa, Senji, Srihari, Sriganesh, Burma, Sandeep and Khanna, Kum Kum (2017). Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae. Molecular Oncology, 11 (5), 470-490. doi: 10.1002/1878-0261.12040 |
|
2014 Journal Article Understanding Sequence Similarity and Framework Analysis Between Centromere Proteins Using Computational BiologyDoss, C. George Priya, Chakrabarty, Chiranjib, Debajyoti, C. and Debottam, S. (2014). Understanding Sequence Similarity and Framework Analysis Between Centromere Proteins Using Computational Biology. Cell Biochemistry and Biophysics, 70 (2), 897-906. doi: 10.1007/s12013-014-9997-1 |
|
2013 Journal Article Disruption of Mitochondrial Complexes in Cancer Stem Cells Through Nano-based Drug Delivery: A Promising Mitochondrial MedicineDoss, C. George Priya, Debajyoti, C. and Debottam, S. (2013). Disruption of Mitochondrial Complexes in Cancer Stem Cells Through Nano-based Drug Delivery: A Promising Mitochondrial Medicine. Cell Biochemistry and Biophysics, 67 (3), 1075-1079. doi: 10.1007/s12013-013-9607-7 |
|
2013 Journal Article Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of RasDoss, C. George Priya, Debottam, S. and Debajyoti, C. (2013). Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras. Protoplasma, 250 (3), 787-792. doi: 10.1007/s00709-012-0451-1 |
|
2012 Journal Article The impact of gold nanoparticles on hTERT gene expression leading to termination of malignant tumorDoss, C. George Priya, Debajyoti, C. and Debottam, S. (2012). The impact of gold nanoparticles on hTERT gene expression leading to termination of malignant tumor. Gene, 493 (1), 140-141. doi: 10.1016/j.gene.2011.11.020 |
|
2012 Conference Publication Studies on the Dielectric properties of Natural Urinary StonesSinha, Debottam, Anwar, K., Kumari, K., Jaishwal, S., Madeshwaran, S., Keshari, S., Babu, D. Rajan, Vidya, R. and Nambiraj, Arunai N. (2012). Studies on the Dielectric properties of Natural Urinary Stones. International Conference on Recent Trends in Advanced Materials (ICRAM 2012), Vellore, India, 20-22 February 2012. Baech, Switzerland: Scientific.Net. doi: 10.4028/www.scientific.net/amr.584.484 |
